Immunoassay Market By Technology, Product, Application and End User - Global Industry Analysis And Forecast To 2027

Published On : November 2018 Pages : 130 Category: Pharma & Healthcare Report Code : HC121935

SEGMENTS & REGIONS:

  • Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa

Immunoassay Market By Technology (Radioimmunoassay (RIA), Enzyme-linked Immunofluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunoassay (ELISA) and Others); Product (Consumables and Analyzer); Application (Orthopedics, Oncology, Infectious Disease, Cardiology, Endocrinology and Others); and End User (Blood Banks, Hospitals and Diagnostics Laboratories and Others); - Global Industry Analysis And Forecast To 2027 

Industry Outlook

Immunoassay is a biochemical procedure used for measuring the presence and concentration of analytes like proteins, lipids, nucleic acid, etc., in a solution like serum, urine, etc. by antibody-antigen reactions. Immunoassay diagnostic tests are been used widely in blood banks, research labs, diagnostic labs and hospitals for many years. Use of Immunoassay is rising due to following factors; wide number of applications (like diagnosis of prolonged disorders also infectious diseases, forecasting of disease course, formulating treatment, etc.), studying different biological systems in life science sector, developing preventive health care techniques (for aged people, people with prolonged disorders), development of different systems which are completely automated for diagnosis, etc. Therefore, the Immunoassay Market is anticipated to expand and has tremendous scope during the forecast period. The global Immunoassay Market anticipated to flourish in the future by growing at a significantly higher CAGR.

Market Segmentation

The global Immunoassay Market is based on segment, by Technology the market is segmented into Radioimmunoassay (RIA), Enzyme-linked Immunofluorescent Assay (ELFA), Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunoassay (ELISA) and Others; by Product the market is segmented into Consumables and Analyzer; by Application the market is segmented into Orthopedics, Oncology, Infectious Disease, Cardiology, Endocrinology and Others; and by End User the market is segmented into Blood Banks, Hospitals and Diagnostics Laboratories and Others.

  • Immunoassay Market, By Technology
  • Radioimmunoassay (RIA)
  • Enzyme-linked Immunofluorescent Assay (ELFA)
  • Chemiluminescence Immunoassay (CLIA)
  • Enzyme-linked Immunoassay (ELISA)
  • Others
  • Immunoassay Market, By Product
  • Consumables
  • Analyzer
  • Immunoassay Market, By Application
  • Orthopedics
  • Oncology
  • Infectious Disease
  • Cardiology
  • Endocrinology
  • Others
  • Immunoassay Market, By End User
  • Blood Banks
  • Hospitals and Diagnostics Laboratories
  • Others

Regional Insights

On a global front, the Immunoassay Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Immunoassay Market followed by European region due the factors; growing aged population, set-up of number of pharmaceutical and biotechnology companies and highly developed healthcare sector.

Immunoassay Market, By Region

    • North America
  • U.S.
  • Canada
  • Mexico
    • Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
    • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Rest of Asia-Pacific
    • South America
  • Brazil
  • Argentina
  • Columbia
  • Rest of South America
    • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Nigeria
  • South Africa
  • Rest of MEA

Competitive Analysis

The leading players in the market are DiaSorin S.p.A, Merck KGaA, Danaher Corporation, Ortho Clinical Diagnostics (a part of Carlyle Group),  Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Abbott Laboratories, bioMérieux SA, Sysmex Corporation, Siemens Healthineers (Siemens AG), and F. Hoffmann-La Roche AG.. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.

  • DiaSorin S.p.A
  • Merck KGaA
  • Danaher Corporation
  • Ortho Clinical Diagnostics (a part of Carlyle Group)
  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson and Company
  • Abbott Laboratories
  • bioMérieux SA
  • Sysmex Corporation
  • Siemens Healthineers (Siemens AG)
  • F. Hoffmann-La Roche AG

Some of the key questions answered by the report are:          

  • What was the market size in 2017 and forecast from 2017 to 2027?
  • What will be the industry market growth from 2017 to 2027?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

o   Immunoassay Market, By Technology, Estimates and Forecast, 2017-2027 ($Million)

o   Radioimmunoassay (RIA)

o   Enzyme-linked Immunofluorescent Assay (ELFA)

o   Chemiluminescence Immunoassay (CLIA)

o   Enzyme-linked Immunoassay (ELISA)

o   Others

o   Immunoassay Market, By Product, Estimates and Forecast, 2017-2027 ($Million)

o   Consumables

o   Analyzer

o   Immunoassay Market, By Application, Estimates and Forecast, 2017-2027 ($Million)

o   Orthopedics

o   Oncology

o   Infectious Disease

o   Cardiology

o   Endocrinology

o   Others

o   Immunoassay Market, By End-User, Estimates and Forecast, 2017-2027 ($Million)

o   Blood Banks

o   Hospitals and Diagnostics Laboratories

o   Others

o   Immunoassay Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

o   North America

§  North America Immunoassay Market, By Country

o   U.S. Immunoassay Market

o   Canada Immunoassay Market

o   Mexico Immunoassay Market

o   Europe

§  Europe Immunoassay Market, By Country

o   Germany Immunoassay Market

o   UK Immunoassay Market

o   France Immunoassay Market

o   Russia Immunoassay Market

o   Italy Immunoassay Market

o   Rest of Europe Immunoassay Market

o   Asia-Pacific

§  Asia-Pacific Immunoassay Market, By Country

o   China Immunoassay Market

o   Japan Immunoassay Market

o   South Korea  Immunoassay Market

o   India Immunoassay Market

o   Southeast Asia Immunoassay Market

o   Rest of Asia-Pacific Immunoassay Market

o   South America

§  South America Immunoassay Market, By Country

o   Brazil Immunoassay Market

o   Argentina Immunoassay Market

o   Columbia Immunoassay Market

o   Rest of South America Immunoassay Market

o   Middle East and Africa

§  Middle East and Africa Immunoassay Market, By Country

o   Saudi Arabia Immunoassay Market

o   UAE Immunoassay Market

o   Egypt Immunoassay Market

o   Nigeria Immunoassay Market

o   South Africa Immunoassay Market

o   Rest of MEA Immunoassay Market

Table of Contents:

1.       Introduction

1.1.     Report Description

2.       Executive Summary

2.1.     Key Highlights

3.       Market Overview

3.1.     Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.     Market Dynamics

3.2.1.  Drivers

3.2.2.  Restraints

3.2.3.  Opportunities

3.3.     SWOT Analysis

4.       Market Analysis by Regions

4.1.     North America (United States, Canada and Mexico)

4.1.1.  United States Market States and Outlook (2017-2027)

4.1.2.  Canada Market States and Outlook (2017-2027)

4.1.3.  Mexico Market States and Outlook (2017-2027)

4.2.     Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1.  Germany Market States and Outlook (2017-2027)

4.2.2.  France Market States and Outlook (2017-2027)

4.2.3.  UK Market States and Outlook (2017-2027)

4.2.4.  Russia Market States and Outlook (2017-2027)

4.2.5.  Italy Market States and Outlook (2017-2027)

4.2.6.  Rest of Europe Market States and Outlook (2017-2027)

4.3.     Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1.  China Market States and Outlook (2017-2027)

4.3.2.  Japan Market States and Outlook (2017-2027)

4.3.3.  Korea Market States and Outlook (2017-2027)

4.3.4.  India Market States and Outlook (2017-2027)

4.3.5.  Southeast Asia Market States and Outlook (2017-2027)

4.3.6.  Rest of Asia-Pacific Market States and Outlook (2017-2027)

4.4.     South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1.  Brazil Market States and Outlook (2017-2027)

4.4.2.  Argentina Market States and Outlook (2017-2027)

4.4.3.  Columbia Market States and Outlook (2017-2027)

4.4.4.  Rest of South America Market States and Outlook (2017-2027)

4.5.     Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1.  Saudi Arabia Market States and Outlook (2017-2027)

4.5.2.  United Arab Emirates Market States and Outlook (2017-2027)

4.5.3.  Egypt Market States and Outlook (2017-2027)

4.5.4.  Nigeria Market States and Outlook (2017-2027)

4.5.5.  South Africa Market States and Outlook (2017-2027)

4.5.6.  Turkey Market States and Outlook (2017-2027)

4.5.7.  Rest of Middle East and Africa Market States and Outlook (2017-2027)

5.       Immunoassay Market, By Technology

5.1.     Introduction

5.2.     Global Immunoassay Revenue and Market Share by Technology (2017-2027)

5.2.1.  Global Immunoassay Revenue and Revenue Share by Technology (2017-2027)

5.3.     Radioimmunoassay (RIA)

5.3.1.  Global Radioimmunoassay (RIA) Revenue and Growth Rate (2017-2027)

5.4.     Enzyme-linked Immunofluorescent Assay (ELFA)

5.4.1.  Global Enzyme-linked Immunofluorescent Assay (ELFA) Revenue and Growth Rate (2017-2027)

5.5.     Chemiluminescence Immunoassay (CLIA)

5.5.1.  Global Chemiluminescence Immunoassay (CLIA) Revenue and Growth Rate (2017-2027)

5.6.     Enzyme-linked Immunoassay (ELISA)

5.6.1.  Global Enzyme-linked Immunoassay (ELISA) Revenue and Growth Rate (2017-2027)

5.7.     Others

5.7.1.  Global Others Revenue and Growth Rate (2017-2027)

6.       Immunoassay Market, By  Product

6.1.     Introduction

6.2.     Global Immunoassay Revenue and Market Share by  Product (2017-2027)

6.2.1.  Global Immunoassay Revenue and Revenue Share by  Product (2017-2027)

6.3.     Consumables

6.3.1.  Global Consumables Revenue and Growth Rate (2017-2027)

6.4.     Analyzer

6.4.1.  Global Analyzer Revenue and Growth Rate (2017-2027)

7.       Immunoassay Market, By Application

7.1.     Introduction

7.2.     Global Immunoassay Revenue and Market Share by Application (2017-2027)

7.2.1.  Global Immunoassay Revenue and Revenue Share by Application (2017-2027)

7.3.     Orthopedics

7.3.1.  Global Orthopedics Revenue and Growth Rate (2017-2027)

7.4.     Oncology

7.4.1.  Global Oncology Revenue and Growth Rate (2017-2027)

7.5.     Infectious Disease

7.5.1.  Global Infectious Disease Revenue and Growth Rate (2017-2027)

7.6.     Cardiology

7.6.1.  Global Cardiology Revenue and Growth Rate (2017-2027)

7.7.     Endocrinology

7.7.1.  Global Endocrinology Revenue and Growth Rate (2017-2027)

7.8.     Others

7.8.1.  Global Others Revenue and Growth Rate (2017-2027)

8.       Immunoassay Market, By End User

8.1.     Introduction

8.2.     Global Immunoassay Revenue and Market Share by End User (2017-2027)

8.2.1.  Global Immunoassay Revenue and Revenue Share by End User (2017-2027)

8.3.     Blood Banks

8.3.1.  Global Blood Banks Revenue and Growth Rate (2017-2027)

8.4.     Hospitals and Diagnostics Laboratories

8.4.1.  Global Hospitals and Diagnostics Laboratories Revenue and Growth Rate (2017-2027)

8.5.     Others

8.5.1.  Global Others Revenue and Growth Rate (2017-2027)

9.       Immunoassay Market, By Region

9.1.     Introduction

9.2.     Global Immunoassay Revenue and Market Share by Regions

9.2.1.  Global Immunoassay Revenue by Regions (2017-2027)

9.3.     North America Immunoassay by Countries

9.3.1.  North America Immunoassay Revenue and Growth Rate (2017-2027)

9.3.2.  North America Immunoassay Revenue (Million USD) by Countries (2017-2027)

9.3.3.  United States

9.3.3.1.  United States Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.4.  Canada

9.3.4.1.  Canada Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.3.5.  Mexico

9.3.5.1.  Mexico Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.     Europe Immunoassay by Countries

9.4.1.  Europe Immunoassay Revenue and Growth Rate (2017-2027)

9.4.2.  Europe Immunoassay Revenue (Million USD) by Countries (2017-2027)

9.4.3.  Germany

9.4.3.1.  Germany Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.4.  France

9.4.4.1.  France Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.5.  UK

9.4.5.1.  UK Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.6.  Russia

9.4.6.1.  Russia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.7.  Italy

9.4.7.1.  Italy Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.4.8.  Rest of Europe

9.4.8.1.  Rest of Europe Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.     Asia-Pacific Immunoassay by Countries

9.5.1.  Asia-Pacific Immunoassay Revenue and Growth Rate (2017-2027)

9.5.2.  Asia-Pacific Immunoassay Revenue (Million USD) by Countries (2017-2027)

9.5.3.  China

9.5.3.1.  China Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.4.  Japan

9.5.4.1.  Japan Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.5.  Korea

9.5.5.1.  Korea Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.6.  India

9.5.6.1.  India Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.7.  Southeast Asia

9.5.7.1.  Southeast Asia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.5.8.  Rest of Asia-Pacific

9.5.8.1.  Rest of Asia-Pacific Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.     South America Immunoassay by Countries

9.6.1.  South America Immunoassay Revenue and Growth Rate (2017-2027)

9.6.2.  South America Immunoassay Revenue (Million USD) by Countries (2017-2027)

9.6.3.  Brazil

9.6.3.1.  Brazil Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.4.  Argentina

9.6.4.1.  Argentina Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.5.  Columbia

9.6.5.1.  Columbia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.6.6.  Rest of South America

9.6.6.1.  Rest of South America Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.     Middle East and Africa Immunoassay by Countries

9.7.1.  Middle East and Africa Immunoassay Revenue and Growth Rate (2017-2027)

9.7.2.  Middle East and Africa Immunoassay Revenue (Million USD) by Countries (2017-2027)

9.7.3.  Saudi Arabia

9.7.3.1.  Saudi Arabia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.4.  United Arab Emirates

9.7.4.1.  United Arab Emirates Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.5.  Egypt

9.7.5.1.  Egypt Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.6.  Nigeria

9.7.6.1.  Nigeria Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.7.  South Africa

9.7.7.1.  South Africa Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.8.  Turkey

9.7.8.1.  Turkey Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

9.7.9.  Rest of Middle East and Africa

9.7.9.1.  Rest of Middle East and Africa Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

10.    Company Profiles

10.1. DiaSorin S.p.A

10.1.1.      Business Overview

10.1.2.       Service Portfolio

10.1.3.      Strategic Developments

10.1.4.       Revenue and Market Share

10.2. Merck KGaA

10.2.1.      Business Overview

10.2.2.       Service Portfolio

10.2.3.      Strategic Developments

10.2.4.       Revenue and Market Share

10.3. Danaher Corporation

10.3.1.      Business Overview

10.3.2.       Service Portfolio

10.3.3.      Strategic Developments

10.3.4.       Revenue and Market Share

10.4. Ortho Clinical Diagnostics (a part of Carlyle Group)

10.4.1.      Business Overview

10.4.2.       Service Portfolio

10.4.3.      Strategic Developments

10.4.4.       Revenue and Market Share

10.5. Thermo Fisher Scientific Inc.

10.5.1.      Business Overview

10.5.2.       Service Portfolio

10.5.3.      Strategic Developments

10.5.4.       Revenue and Market Share

10.6. Becton, Dickinson and Company

10.6.1.      Business Overview

10.6.2.       Service Portfolio

10.6.3.      Strategic Developments

10.6.4.       Revenue and Market Share

10.7. Abbott Laboratories

10.7.1.      Business Overview

10.7.2.       Service Portfolio

10.7.3.      Strategic Developments

10.7.4.       Revenue and Market Share

10.8. bioMérieux SA

10.8.1.      Business Overview

10.8.2.       Service Portfolio

10.8.3.      Strategic Developments

10.8.4.       Revenue and Market Share

10.9. Sysmex Corporation

10.9.1.      Business Overview

10.9.2.       Service Portfolio

10.9.3.      Strategic Developments

10.9.4.       Revenue and Market Share

10.10.                   Siemens Healthineers (Siemens AG)

10.10.1.  Business Overview

10.10.2.   Service Portfolio

10.10.3.  Strategic Developments

10.10.4.   Revenue and Market Share

10.11.                   F. Hoffmann-La Roche AG

10.11.1.  Business Overview

10.11.2.   Service Portfolio

10.11.3.  Strategic Developments

10.11.4.   Revenue and Market Share

11.    Global Immunoassay Market Competition, by Manufacturer

11.1. Global Immunoassay Revenue and Market Share by Manufacturer (2017-2017)

11.2. Global Immunoassay Price By Region (2017-2017)

11.3. Top 5 Immunoassay Manufacturer Market Share

11.4. Market Competition Trend

12.    Immunoassay Market Forecast (2017-2027)

12.1. Global Immunoassay Revenue (Millions USD) and Growth Rate (2017-2027)

12.2. Immunoassay Market Forecast by Regions (2017-2027)

12.2.1.      North America Immunoassay Market Forecast (2017-2027)

12.2.1.1. United States Immunoassay Market Forecast (2017-2027)

12.2.1.2. Canada Immunoassay Market Forecast (2017-2027)

12.2.1.3. Mexico Immunoassay Market Forecast (2017-2027)

12.2.2.      Europe Immunoassay Market Forecast (2017-2027)

12.2.2.1. Germany Immunoassay Market Forecast (2017-2027)

12.2.2.2. France Immunoassay Market Forecast (2017-2027)

12.2.2.3. UK Immunoassay Market Forecast (2017-2027)

12.2.2.4. Russia Immunoassay Market Forecast (2017-2027)

12.2.2.5. Italy Immunoassay Market Forecast (2017-2027)

12.2.2.6. Rest of Europe Immunoassay Market Forecast (2017-2027)

12.2.3.      Asia-Pacific Immunoassay Market Forecast (2017-2027)

12.2.3.1. China Immunoassay Market Forecast (2017-2027)

12.2.3.2. Japan Immunoassay Market Forecast (2017-2027)

12.2.3.3. Korea Immunoassay Market Forecast (2017-2027)

12.2.3.4. India Immunoassay Market Forecast (2017-2027)

12.2.3.5. Southeast Asia Immunoassay Market Forecast (2017-2027)

12.2.3.6. Rest of Asia-Pacific Immunoassay Market Forecast (2017-2027)

12.2.4.      South America Immunoassay Market Forecast (2017-2027)

12.2.4.1. Brazil Immunoassay Market Forecast (2017-2027)

12.2.4.2. Argentina Immunoassay Market Forecast (2017-2027)

12.2.4.3. Columbia Immunoassay Market Forecast (2017-2027)

12.2.4.4. Rest of South America Immunoassay Market Forecast (2017-2027)

12.2.5.      Middle East and Africa Immunoassay Market Forecast (2017-2027)

12.2.5.1. Saudi Arabia Immunoassay Market Forecast (2017-2027)

12.2.5.2. United Arab Emirates Immunoassay Market Forecast (2017-2027)

12.2.5.3. Egypt Immunoassay Market Forecast (2017-2027)

12.2.5.4. Nigeria Immunoassay Market Forecast (2017-2027)

12.2.5.5. South Africa Immunoassay Market Forecast (2017-2027)

12.2.5.6. Turkey Immunoassay Market Forecast (2017-2027)

12.2.5.7. Rest of Middle East and Africa Immunoassay Market Forecast (2017-2027)

12.3. Immunoassay Market Forecast by Technology (2017-2027)

12.3.1.      Immunoassay Forecast by Technology (2017-2027)

12.3.2.      Immunoassay Market Share Forecast by Technology (2017-2027)

12.4. Immunoassay Market Forecast by  Product (2017-2027)

12.4.1.      Immunoassay Forecast by  Product (2017-2027)

12.4.2.      Immunoassay Market Share Forecast by  Product (2017-2027)

12.5. Immunoassay Market Forecast by Application (2017-2027)

12.5.1.      Immunoassay Forecast by Application (2017-2027)

12.5.2.      Immunoassay Market Share Forecast by Application (2017-2027)

12.6. Immunoassay Market Forecast by End User (2017-2027)

12.6.1.      Immunoassay Forecast by End User (2017-2027)

12.6.2.      Immunoassay Market Share Forecast by End User (2017-2027)


List of Tables

List of Tables and Figures:

Figure United States Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Immunoassay Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Immunoassay Revenue and Revenue Share by Technology (2017-2018)
Figure Global Radioimmunoassay (RIA) Revenue and Growth Rate (2017-2018)
Figure Global Enzyme-linked Immunofluorescent Assay (ELFA) Revenue and Growth Rate (2017-2018)
Figure Global Chemiluminescence Immunoassay (CLIA) Revenue and Growth Rate (2017-2018)
Figure Global Enzyme-linked Immunoassay (ELISA) Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Immunoassay Revenue and Revenue Share by Product (2017-2018)
Figure Global Consumables Revenue and Growth Rate (2017-2018)
Figure Global Analyzer Revenue and Growth Rate (2017-2018)
Table Global Immunoassay Revenue and Revenue Share by Application (2017-2018)
Figure Global Orthopedics Revenue and Growth Rate (2017-2018)
Figure Global Oncology Revenue and Growth Rate (2017-2018)
Figure Global Infectious Disease Revenue and Growth Rate (2017-2018)
Figure Global Cardiology Revenue and Growth Rate (2017-2018)
Figure Global Endocrinology Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Immunoassay Revenue and Revenue Share by End User (2017-2018)
Figure Global Blood Banks Revenue and Growth Rate (2017-2018)
Figure Global Hospitals and Diagnostics Laboratories Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Immunoassay Revenue by Regions (2017-2018)
Figure North America Immunoassay Growth Rate (2017-2018)
Figure North America Immunoassay Revenue and Growth Rate (2017-2018)
Figure North America Immunoassay by Countries (2017-2018)
Figure North America Immunoassay Revenue (Million USD) by Countries (2017-2018)
Figure United States Immunoassay Growth Rate (2017-2018)
Figure United States Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Immunoassay Growth Rate (2017-2018)
Figure Canada Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Immunoassay Growth Rate (2017-2018)
Figure Mexico Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Immunoassay Growth Rate (2017-2018)
Figure Europe Immunoassay Revenue and Growth Rate (2017-2018)
Figure Europe Immunoassay by Countries (2017-2018)
Figure Europe Immunoassay Revenue (Million USD) by Countries (2017-2018)
Figure Germany Immunoassay Growth Rate (2017-2018)
Figure Germany Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Immunoassay Growth Rate (2017-2018)
Figure France Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Immunoassay Growth Rate (2017-2018)
Figure UK Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Immunoassay Growth Rate (2017-2018)
Figure Russia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Immunoassay Growth Rate (2017-2018)
Figure Italy Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Immunoassay Growth Rate (2017-2018)
Figure Rest of Europe Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Immunoassay Growth Rate (2017-2018)
Figure Asia-Pacific Immunoassay Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Immunoassay by Countries (2017-2018)
Figure Asia-Pacific Immunoassay Revenue (Million USD) by Countries (2017-2018)
Figure China Immunoassay Growth Rate (2017-2018)
Figure China Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Immunoassay Growth Rate (2017-2018)
Figure Japan Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Immunoassay Growth Rate (2017-2018)
Figure Korea Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Immunoassay Growth Rate (2017-2018)
Figure India Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Immunoassay Growth Rate (2017-2018)
Figure Southeast Asia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunoassay Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Immunoassay Growth Rate (2017-2018)
Figure South America Immunoassay Revenue and Growth Rate (2017-2018)
Figure South America Immunoassay by Countries (2017-2018)
Figure South America Immunoassay Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Immunoassay Growth Rate (2017-2018)
Figure Brazil Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Immunoassay Growth Rate (2017-2018)
Figure Argentina Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Immunoassay Growth Rate (2017-2018)
Figure Columbia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Immunoassay Growth Rate (2017-2018)
Figure Rest of South America Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Immunoassay Growth Rate (2017-2018)
Figure Middle East and Africa Immunoassay Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Immunoassay by Countries (2017-2018)
Figure Middle East and Africa Immunoassay Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Immunoassay Growth Rate (2017-2018)
Figure Saudi Arabia Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Immunoassay Growth Rate (2017-2018)
Figure United Arab Emirates Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Immunoassay Growth Rate (2017-2018)
Figure Egypt Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Immunoassay Growth Rate (2017-2018)
Figure Nigeria Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Immunoassay Growth Rate (2017-2018)
Figure South Africa Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Immunoassay Growth Rate (2017-2018)
Figure Turkey Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunoassay Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Immunoassay Revenue (Millions USD) and Growth Rate (2017-2018)
Table DiaSorin S.p.A Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck KGaA Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Danaher Corporation Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ortho Clinical Diagnostics (a part of Carlyle Group) Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Becton, Dickinson and Company Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abbott Laboratories Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table bioMérieux SA Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sysmex Corporation Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Siemens Healthineers (Siemens AG) Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Table F. Hoffmann-La Roche AG Immunoassay Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Immunoassay Market Share by Manufacturer
Figure Global Immunoassay Revenue and Market Share by Manufacturer
Table Global Immunoassay Price by Region (2017-2017)
Figure Top 5 Immunoassay Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Immunoassay Revenue (Millions USD) and Growth Rate (2018-2025)
Table Immunoassay Market Forecast by Regions (2018-2025)
Figure North America Immunoassay Market Forecast (2018-2025)
Figure United States Immunoassay Market Forecast (2018-2025)
Figure Canada Immunoassay Market Forecast (2018-2025)
Figure Mexico Immunoassay Market Forecast (2018-2025)
Figure Europe Immunoassay Market Forecast (2018-2025)
Figure Germany Immunoassay Market Forecast (2018-2025)
Figure France Immunoassay Market Forecast (2018-2025)
Figure UK Immunoassay Market Forecast (2018-2025)
Figure Russia Immunoassay Market Forecast (2018-2025)
Figure Italy Immunoassay Market Forecast (2018-2025)
Figure Rest of Europe Immunoassay Market Forecast (2018-2025)
Figure Asia-Pacific Immunoassay Market Forecast (2018-2025)
Figure China Immunoassay Market Forecast (2018-2025)
Figure Japan Immunoassay Market Forecast (2018-2025)
Figure Korea Immunoassay Market Forecast (2018-2025)
Figure India Immunoassay Market Forecast (2018-2025)
Figure Southeast Asia Immunoassay Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Immunoassay Market Forecast (2018-2025)
Figure South America Immunoassay Market Forecast (2018-2025)
Figure Brazil Immunoassay Market Forecast (2018-2025)
Figure Argentina Immunoassay Market Forecast (2018-2025)
Figure Columbia Immunoassay Market Forecast (2018-2025)
Figure Rest of South America Immunoassay Market Forecast (2018-2025)
Figure Middle East and Africa Immunoassay Market Forecast (2018-2025)
Figure Saudi Arabia Immunoassay Market Forecast (2018-2025)
Figure United Arab Emirates Immunoassay Market Forecast (2018-2025)
Figure Egypt Immunoassay Market Forecast (2018-2025)
Figure Nigeria Immunoassay Market Forecast (2018-2025)
Figure South Africa Immunoassay Market Forecast (2018-2025)
Figure Turkey Immunoassay Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Immunoassay Market Forecast (2018-2025)
Figure Global Immunoassay Forecast by Technology (2018-2025)
Figure Global Immunoassay Market Share Forecast by Technology (2018-2025)
Figure Global Immunoassay Forecast by Technology (2018-2025)
Figure Global Immunoassay Forecast by Product (2018-2025)
Figure Global Immunoassay Market Share Forecast by Product (2018-2025)
Figure Global Immunoassay Forecast by Product (2018-2025)
Figure Global Immunoassay Forecast by Application (2018-2025)
Figure Global Immunoassay Market Share Forecast by Application (2018-2025)
Figure Global Immunoassay Forecast by Application (2018-2025)
Figure Global Immunoassay Forecast by End User (2018-2025)
Figure Global Immunoassay Market Share Forecast by End User (2018-2025)
Figure Global Immunoassay Forecast by End User (2018-2025)


Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country